v ::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::
ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

EFFECT OF LOW CARBOHYDRATE DIET FOR DIABETES MELLITUS MANAGEMENT

AUTHORS:

Dr Adeela Sarfraz Khan, Dr. Maheen Zafar, Dr Anbreen Shabbir

ABSTRACT:

Introduction: Type 2 diabetes is characterized by a chronic metabolic disorder associated with relative insulin deficiency arising as a result of the secretion defect and / or insulin resistance. Today, the disorder is classified as a civilization disease and its incidence continues to increase. Objectives of the study: The purpose of the presented study is to verify the current state of knowledge concerning usage of low-carbohydrate diets in type 2 diabetes, and to present the benefits and risks associated with the given nutrition in these patients. Methodology of the study: This descriptive cross sectional study was conducted at Bahawal Victoria Hospital, Bahawalpur during June 2019 to June 2020. There was 100 patients which was visit the hospital during this time period. We assess the nutritional and economic health of patients by asking some survey questions. Analysis and results: The data was collected from 100 male and females patients who visit the hospitals. The analysis of the data shows that diabetes is more common in females as compared to males. The reason is that because women have different conditions and working environment as compared to males. The relationship between dietary intake, BMI and diet quality among diabetic patients shows that people consume more protein and fat as compared to carbohydrates. Due to this reason they may suffer from other diseases parallel to diabetes. Conclusion: It is concluded that carbohydrate diet has direct effect on type 2 diabetes patients. Healthy eating pattern may lead towards the control of this diseases otherwise the condition get worse.

FULL TEXT

<
Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.